RESUMEN
Lentiviruses are infectious agents of a number of animal species, including sheep, goats, horses, monkeys, cows, and cats, in addition to humans. As in the human case, the host immune response fails to control the establishment of chronic persistent infection that finally leads to a specific disease development. Despite intensive research on the development of lentivirus vaccines, it is still not clear which immune responses can protect against infection. Viral mutations resulting in escape from T-cell or antibody-mediated responses are the basis of the immune failure to control the infection. The innate immune response provides the first line of defense against viral infections in an antigen-independent manner. Antiviral innate responses are conducted by dendritic cells, macrophages, and natural killer cells, often targeted by lentiviruses, and intrinsic antiviral mechanisms exerted by all cells. Intrinsic responses depend on the recognition of the viral pathogen-associated molecular patterns (PAMPs) by pathogen recognition receptors (PRRs), and the signaling cascades leading to an antiviral state by inducing the expression of antiviral proteins, including restriction factors. This review describes the latest advances on innate immunity related to the infection by animal lentiviruses, centered on small ruminant lentiviruses (SRLV), equine infectious anemia virus (EIAV), and feline (FIV) and bovine immunodeficiency viruses (BIV), specifically focusing on the antiviral role of the major restriction factors described thus far.
Asunto(s)
Regulación de la Expresión Génica/inmunología , Inmunidad Innata , Factores Reguladores del Interferón/inmunología , Infecciones por Lentivirus/inmunología , Receptores de Reconocimiento de Patrones/inmunología , Animales , Gatos , Bovinos , Células Dendríticas/inmunología , Células Dendríticas/virología , Cabras , Caballos , Virus de la Inmunodeficiencia Bovina/inmunología , Virus de la Inmunodeficiencia Bovina/patogenicidad , Virus de la Inmunodeficiencia Felina/inmunología , Virus de la Inmunodeficiencia Felina/patogenicidad , Virus de la Anemia Infecciosa Equina/inmunología , Virus de la Anemia Infecciosa Equina/patogenicidad , Factores Reguladores del Interferón/genética , Células Asesinas Naturales/inmunología , Células Asesinas Naturales/virología , Infecciones por Lentivirus/genética , Infecciones por Lentivirus/virología , Macrófagos/inmunología , Macrófagos/virología , Moléculas de Patrón Molecular Asociado a Patógenos/inmunología , Receptores de Reconocimiento de Patrones/genética , Ovinos , Linfocitos T/inmunología , Linfocitos T/virologíaRESUMEN
Influenza VLPs comprised of hemagglutinin (HA), neuraminidase (NA), and matrix (M1) proteins have been previously used for immunological and virological studies. Here we demonstrated that influenza VLPs can be made in Sf9 cells by using the bovine immunodeficiency virus gag (Bgag) protein in place of M1. We showed that Bgag can be used to prepare VLPs for several influenza subtypes including H1N1 and H10N8. Furthermore, by using Bgag, we prepared quadri-subtype VLPs, which co-expressed within the VLP the four HA subtypes derived from avian-origin H5N1, H7N9, H9N2 and H10N8 viruses. VLPs showed hemagglutination and neuraminidase activities and reacted with specific antisera. The content and co-localization of each HA subtype within the quadri-subtype VLP were evaluated. Electron microscopy showed that Bgag-based VLPs resembled influenza virions with the diameter of 150-200nm. This is the first report of quadri-subtype design for influenza VLP and the use of Bgag for influenza VLP preparation.
Asunto(s)
Productos del Gen gag/inmunología , Glicoproteínas Hemaglutininas del Virus de la Influenza/inmunología , Virus de la Inmunodeficiencia Bovina/inmunología , Neuraminidasa/inmunología , Vacunas de Partículas Similares a Virus/inmunología , Animales , Anticuerpos Antivirales/inmunología , Línea Celular , Productos del Gen gag/genética , Virus de la Inmunodeficiencia Bovina/genética , Subtipo H10N8 del Virus de la Influenza A/genética , Subtipo H10N8 del Virus de la Influenza A/inmunología , Subtipo H1N1 del Virus de la Influenza A/genética , Subtipo H1N1 del Virus de la Influenza A/inmunología , Subtipo H5N1 del Virus de la Influenza A/genética , Subtipo H5N1 del Virus de la Influenza A/inmunología , Subtipo H7N9 del Virus de la Influenza A/genética , Subtipo H7N9 del Virus de la Influenza A/inmunología , Subtipo H9N2 del Virus de la Influenza A/genética , Subtipo H9N2 del Virus de la Influenza A/inmunología , Insectos , Infecciones por Orthomyxoviridae/inmunología , Infecciones por Orthomyxoviridae/prevención & control , Infecciones por Orthomyxoviridae/virología , Células Sf9 , SpodopteraRESUMEN
In cattle the interaction between the two genetically and antigenically related bovine lentiviruses, the acutely pathogenic Jembrana disease virus (JDV) and the non-pathogenic Bovine immunodeficiency virus (BIV) has not been reported although both JDV and a BIV-like virus have been reported in the Bali cattle (Bos javanicus) population in Indonesia. The outcome of infection of Bali cattle with the R29 strain of BIV prior to superinfection 42 days later with JDV(TAB/87) was determined. All BIV-inoculated cattle were successfully infected and developed an antibody response to the TM and CA proteins. BIV infection did not prevent subsequent infection with JDV or ameliorate the clinical signs of Jembrana disease in the infected cattle. It did, however, modify the dynamics of the JDV infection with an earlier onset and end of the acute disease process, and a reduction in the duration of viremia that exceeded 10(6) genome copies/ml of plasma.
Asunto(s)
Enfermedades de los Bovinos/inmunología , Enfermedades de los Bovinos/virología , Infecciones por Lentivirus/veterinaria , Lentivirus Bovinos/inmunología , Animales , Temperatura Corporal , Bovinos , Ensayo de Inmunoadsorción Enzimática , Virus de la Inmunodeficiencia Bovina/inmunología , Infecciones por Lentivirus/inmunología , Infecciones por Lentivirus/virología , Factores de Tiempo , Carga Viral , ViremiaRESUMEN
Recombinant antibody specific for the capsid (CA) protein of bovine immunodeficiency virus (BIV) was generated in the form of single-chain fragment variable (ScFv) using the phage display technique for affinity selection. The variable heavy (V(H)) and variable light (V(L)) chain gene fragments were recovered from cells of CA-specific hybridoma (9G10) described previously. The V(H) and V(L) DNA fragments were assembled through a flexible linker DNA to generate ScFv fragment which was cloned in a phagemid expression vector to express ScFv protein. The specific reactivity of the expressed ScFv to the CA antigen was confirmed by Western blot, and the ScFv fragment was used to develop a competitive inhibition ELISA for detection of antibodies to BIV in cattle and buffalo. The recombinant antibody was shown to be more than four times sensitive than its parent monoclonal antibody (MAb, 9G10) by testing of spiked samples of reference positive sera. The improved sensitivity of the recombinant antibody-based ELISA was confirmed by the detection of a larger proportion of animals with BIV antibody by it than by the MAb-based ELISA.
Asunto(s)
Anticuerpos Antivirales/sangre , Proteínas de la Cápside/inmunología , Enfermedades de los Bovinos/diagnóstico , Virus de la Inmunodeficiencia Bovina/inmunología , Infecciones por Lentivirus/veterinaria , Anticuerpos de Cadena Única , Virología/métodos , Animales , Búfalos , Bovinos , Enfermedades de los Bovinos/virología , Ensayo de Inmunoadsorción Enzimática/métodos , India , Biblioteca de Péptidos , Sensibilidad y EspecificidadRESUMEN
The aim of this study was to develop a more specific and sensitive competitive inhibition ELISA (CI-ELISA) than the currently used indirect ELISA for detection of antibodies to bovine immunodeficiency virus (BIV) in cattle and buffaloes. Murine monoclonal antibodies (MAbs) were generated against a recombinant capsid (CA) protein of bovine immunodeficiency virus. Of the 13 anti-CA MAbs developed, MAb-9G10 was selected for CI-ELISA based on the maximum inhibition (98%) obtained with reference BIV antibody positive serum. Based on the distribution of percent inhibition of known negative sera (n=50), a cut-off value was set at 40% inhibition. The MAb-based CI-ELISA showed much higher agreement (concordance: 95.4%) than the indirect ELISA (concordance: 77.8%) with Western blot. Out of 672 sera of cattle and buffaloes tested by CI-ELISA from four states of India, 22% (113/516) of cattle and 19% (30/156) of buffalo were sero-positive for BIV with an overall seroprevalence of 21% (143/672) in India.
Asunto(s)
Anticuerpos Monoclonales , Anticuerpos Antivirales/sangre , Enfermedades de los Bovinos/diagnóstico , Ensayo de Inmunoadsorción Enzimática/métodos , Virus de la Inmunodeficiencia Bovina/aislamiento & purificación , Infecciones por Lentivirus/veterinaria , Animales , Anticuerpos Monoclonales/aislamiento & purificación , Western Blotting , Búfalos , Bovinos , Enfermedades de los Bovinos/epidemiología , Enfermedades de los Bovinos/inmunología , Femenino , Virus de la Inmunodeficiencia Bovina/inmunología , India , Infecciones por Lentivirus/diagnóstico , Infecciones por Lentivirus/epidemiología , Infecciones por Lentivirus/inmunología , Ratones , Estudios SeroepidemiológicosRESUMEN
In Indonesia, it is suspected that there are two bovine lentiviruses circulating in the cattle population: a pathogenic Jembrana disease virus (JDV), and a nonpathogenic bovine immunodeficiency-like virus (BIV). Both viruses cross-react antigenically and cannot be differentiated by current serological tests using JDV antigens. To identify possible type-specific epitopes, a series of recombinant protein constructs including the matrix, capsid and nucleocapsid proteins were produced from JDV gag and the expressed proteins were tested by Western blot using JDV and BIV hyperimmune sera. JDV matrix and truncated capsid proteins were recognised by both JDV and BIV hyperimmune sera indicating that there were multiple cross-reactive epitopes present in JDV gag. At least three epitopic regions were identified in these constructs, including the major homology region, by monoclonal antibody binding studies. JDV nucleocapsid recombinant protein was not recognised by either JDV or BIV hyperimmune sera and none of the recombinant gag proteins were able to differentiate between JDV positive sera from Jembrana disease endemic and Jembrana disease-free areas. Additionally, a 40 amino acid recombinant subunit protein encompassing the region recently found to contain an epitope unique to BIV [Zheng, L., Zhang, S., Wood, C., Kapil, S., Wilcox, G.E., Loughin, T.A., Minocha, H.C., 2001. Differentiation of two bovine lentiviruses by a monoclonal antibody on the basis of epitope specificity. Clin. Diagn. Lab. Immunol. 8, 283-287] was tested but was not recognised by either JDV positive sera from Jembrana disease-endemic or Jembrana disease-free areas.
Asunto(s)
Productos del Gen gag/inmunología , Virus de la Inmunodeficiencia Bovina/inmunología , Lentivirus Bovinos/inmunología , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales/inmunología , Bovinos , Reacciones Cruzadas , Mapeo Epitopo , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Proteínas Recombinantes/inmunologíaRESUMEN
The validation of assays for bovine immunodeficiency virus (BIV) in cattle is hampered by the absence of a gold standard. Two tests that often are used to detect BIV are the indirect fluorescent-antibody assay (IFA) and the nested-set polymerase chain-reaction assay (PCR). IFA detects an antibody response whereas PCR detects the provirus in white blood cells. Using Bayesian techniques performed simultaneously on animals from two different dairy herds, we estimated the performance of the IFA and PCR assays and infection prevalence. Bayesian techniques also were used to derive posterior distributions of sensitivities, specificities, and prevalences. The Bayesian estimates were IFA sensitivity=60%, IFA specificity=88%, PCR sensitivity=80%, PCR specificity=86%, Herd A prevalence=20%, and Herd B prevalence=71%. Although PCR was the more sensitive assay, substantial misclassification of infection would be expected in epidemiological studies of BIV regardless of which assay was used.
Asunto(s)
Enfermedades de los Bovinos/epidemiología , Enfermedades de los Bovinos/virología , Virus de la Inmunodeficiencia Bovina/genética , Virus de la Inmunodeficiencia Bovina/inmunología , Infecciones por Lentivirus/veterinaria , Animales , Anticuerpos Antivirales/análisis , Teorema de Bayes , Bovinos , Enfermedades de los Bovinos/sangre , Enfermedades de los Bovinos/prevención & control , ADN Viral/análisis , Industria Lechera , Femenino , Técnica del Anticuerpo Fluorescente Indirecta/normas , Virus de la Inmunodeficiencia Bovina/aislamiento & purificación , Infecciones por Lentivirus/epidemiología , Infecciones por Lentivirus/virología , Louisiana/epidemiología , Reacción en Cadena de la Polimerasa/normas , Valor Predictivo de las Pruebas , Prevalencia , Sensibilidad y EspecificidadRESUMEN
A seroepidemiological study of bovine immunodeficiency virus (BIV) and bovine leukemia virus (BLV) infections was conducted in four different cattle herds in Turkey. A total of 300 blood samples were analyzed and 12.3% were found to be positive for anti-BIV p26 antibodies by Western blot analysis and 1.6% positive for anti-BLV gp51 antibodies by an immunodiffusion test. BIV infection was confirmed with the detection of BIV-provirus DNA using the nested polymerase chain reaction. This is the first evidence for the presence of BIV in cattle in Turkey.
Asunto(s)
Enfermedades de los Bovinos/epidemiología , Leucosis Bovina Enzoótica/epidemiología , Virus de la Inmunodeficiencia Bovina/inmunología , Infecciones por Lentivirus/veterinaria , Virus de la Leucemia Bovina/inmunología , Animales , Anticuerpos Antivirales/sangre , Western Blotting/veterinaria , Bovinos , ADN Viral/aislamiento & purificación , Femenino , Virus de la Inmunodeficiencia Bovina/aislamiento & purificación , Inmunodifusión/veterinaria , Infecciones por Lentivirus/epidemiología , Virus de la Leucemia Bovina/aislamiento & purificación , Masculino , Reacción en Cadena de la Polimerasa/veterinaria , Estudios Seroepidemiológicos , Turquía/epidemiologíaRESUMEN
Serological survey of bovine immunodeficiency virus (BIV) and bovine leukemia virus (BLV) infection was conducted in dairy cattle from 10 different regions of Hokkaido, Japan. Among 390 cattle, 11.0% of cattle were BIV-seropositive and 3.3% were BLV-seropositive. Moreover, in two dairy farms, where bovine leukosis has been reported, prevalence of BIV infections were 6.4 and 9.1%, respectively. In contrast, among 150 beef cattle, 16.6% were BIV-seropositive while none was BLV-seropositive. Dual infections with BLV and BIV in dairy cattle were tested by using 107 BLV-seropositive sera, and 20 sera were found BIV-positive (18.7%). These results indicate that BIV infection was widespread in Hokkaido.
Asunto(s)
Leucosis Bovina Enzoótica/epidemiología , Virus de la Inmunodeficiencia Bovina/inmunología , Virus de la Inmunodeficiencia Bovina/aislamiento & purificación , Infecciones por Lentivirus/epidemiología , Infecciones por Lentivirus/veterinaria , Virus de la Leucemia Bovina/inmunología , Virus de la Leucemia Bovina/aislamiento & purificación , Animales , Anticuerpos Antivirales/sangre , Bovinos , Industria Lechera , Leucosis Bovina Enzoótica/inmunología , Leucosis Bovina Enzoótica/virología , Femenino , Japón , Infecciones por Lentivirus/inmunología , Masculino , Carne , Estudios SeroepidemiológicosRESUMEN
The inhibition of HIV expression in vitro by a cocktail of the beta-chemokines MIP-1alpha, MIP-1beta and RANTES provided the initial evidence that HIV utilizes chemokine receptors as co-receptors for infection of cells. Bovine immunodeficiency virus (BIV), a lentivirus, infects a wide variety of leukocyte populations, but the cellular receptor(s) utilized by this virus for infection of cells is not known. The purpose of this study was to determine whether MIP-1alpha, MIP-1beta and RANTES affect BIV expression in vitro, as a prelude to identifying the cellular receptors utilized by this virus. Fetal bovine lung (FBL) cells were pretreated with serial dilutions of a cocktail of the chemokines, and then the cells were infected with BIV. Virus expression in these cells was determined by counting the syncytia that had developed in the cultures by five days after infection. A significant decrease in syncytium formation, corresponding to increasing concentrations of the chemokines, was the result. Reacting the chemokines with chemokine-specific neutralizing antibodies prior to treatment of the cells neutralized the effect of the chemokines on virus replication in a dose-dependent manner, restoring viral expression to a level similar to that of untreated cells. The presence of a CCR5 homologue on the surface of FBL cells was confirmed using an anti-CCR5 monoclonal antibody and FACS analysis. Collectively, these data provide preliminary evidence that BIV may utilize the CCR5 receptor for infection of cells in vitro, but additional studies are necessary to confirm this.
Asunto(s)
Enfermedades de los Bovinos/inmunología , Quimiocina CCL5/inmunología , Regulación Viral de la Expresión Génica/inmunología , Virus de la Inmunodeficiencia Bovina/inmunología , Infecciones por Lentivirus/veterinaria , Proteínas Inflamatorias de Macrófagos/inmunología , Animales , Bovinos , Enfermedades de los Bovinos/virología , Células Cultivadas , Quimiocina CCL3 , Quimiocina CCL4 , Citometría de Flujo , Virus de la Inmunodeficiencia Bovina/crecimiento & desarrollo , Infecciones por Lentivirus/inmunología , Infecciones por Lentivirus/virología , Receptores CCR5/análisis , Receptores CCR5/inmunologíaRESUMEN
Vertical transmission of bovine leukemia virus (BLV) and bovine immunodeficiency virus (BIV) was investigated in five dairy cattle herds in Hokkaido, where 36.1 and 17.0% of cattle were BLV and BIV seropositive, respectively, and 9.9% of dams were co-infected with both BIV and BLV. Twenty six cases of offspring born from dams infected with only BLV (17 cases) or with both BIV and BLV (9 cases) were examined for the presence of BLV and BIV before and after colostrum feeding by polymerase chain reaction (PCR) and syncytium assay. After birth, all calves were separated immediately from their dams. The offspring born from BLV-positive dams were BLV-negative before colostrum feeding, suggesting that no transplacental transmission had occurred. Thereafter, these offspring were fed colostrum or milk from their dams, but still remained BLV-negative. The other offspring born from BLV-positive dams were fed with BLV-negative colostrum, or with pasteurized BLV-positive colostrum. All these calves remained negative for BLV infection, suggesting that in utero transmission of BLV is negligible. In the case of offspring born from dams co-infected with BLV and BIV, calves were BIV-positive before colostrum feeding at 1 day after the birth, indicating in utero transmission of BIV. After colostrum feeding from their dams, newborn calves became BLV-positive. In addition, one calf was BLV-positive even before colostrum feeding. These results suggest that BIV can be transmitted to offspring in utero, and that BLV can be transmitted through colostrum or milk if dams are infected with both BIV and BLV.
Asunto(s)
Enfermedades de los Bovinos/transmisión , Leucosis Bovina Enzoótica/transmisión , Virus de la Inmunodeficiencia Bovina , Transmisión Vertical de Enfermedad Infecciosa/veterinaria , Infecciones por Lentivirus/veterinaria , Animales , Anticuerpos Antivirales/sangre , Bovinos , Enfermedades de los Bovinos/epidemiología , Calostro/virología , Leucosis Bovina Enzoótica/epidemiología , Femenino , Virus de la Inmunodeficiencia Bovina/inmunología , Japón/epidemiología , Infecciones por Lentivirus/epidemiología , Infecciones por Lentivirus/transmisión , Virus de la Leucemia Bovina/inmunología , Leche/virología , Reacción en Cadena de la Polimerasa/veterinaria , Estudios SeroepidemiológicosRESUMEN
Bovine immunodeficiency virus (BIV) and Jembrana disease virus (JDV) are bovine lentiviruses that are closely related genetically. A recombinant fusion protein containing the capsid protein of BIV expressed in Escherichia coli was used to immunize mice and produce monoclonal antibodies. Six hybridomas specific for BIV capsid protein were identified, and one antibody, designated 10H1, was characterized further. Competitive binding assays were performed to analyze the topography of antigenic determinants by enzyme-linked immunosorbent assay and demonstrated the existence of at least three distinct antigenic determinants on capsid protein. The monoclonal antibody reacted specifically with both BIV capsid and the recombinant fusion protein in Western immunoblot analyses. However, it did not react with the recombinant capsid fusion protein of JDV, indicating that BIV contains at least one unique epitope in the capsid protein that is absent in JDV. Further mapping of the epitope by chemical cleavage analysis identified that the epitope is located at the 6.4-kDa N terminus of the 29-kDa capsid protein. This monoclonal antibody assay will be valuable for distinguishing the two closely related lentiviruses by Western blotting.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Especificidad de Anticuerpos , Enfermedades de los Bovinos/diagnóstico , Virus de la Inmunodeficiencia Bovina/inmunología , Infecciones por Lentivirus/diagnóstico , Animales , Antígenos de Neoplasias , Cápside/inmunología , Bovinos , Enfermedades de los Bovinos/inmunología , Diagnóstico Diferencial , Ensayo de Inmunoadsorción Enzimática , Epítopos/inmunología , Hibridomas , Virus de la Inmunodeficiencia Bovina/aislamiento & purificación , Cadenas kappa de Inmunoglobulina , Infecciones por Lentivirus/inmunología , Infecciones por Lentivirus/veterinaria , Ratones , Ratones Endogámicos BALB C , Células Tumorales CultivadasRESUMEN
Since bovine immunodeficiency virus (BIV), known as bovine lentivirus, has been detected in dairy and beef cattle in various countries around the world, a prevalence study of antibodies to BIV and bovine leukemia virus (BLV) was conducted in draught animals in five provinces in Cambodia, where protozoan parasite infections were suspected in some animals. To clarify the status of draught animals including Haryana, Brahman, mixed-breed, local breed cattle and muscle water buffaloes, a total of 544 cattle and 42 buffaloes were tested, and 26.3 and 16.7%, respectively, were found positive for anti-BIV p26 antibodies determined by Western blotting. There were 5.3% positive for anti-BLV antibodies detected by immunodiffusion test among the cattle, but no reactors among buffaloes and no dual infection for both BIV and BLV was determined in this study. Peripheral blood mononuclear cells from BIV-seropositive cattle were found to have BIV-provirus DNA, as detected by polymerase chain reaction and subsequent Southern blot hybridization. This is the first evidence for the presence of BIV and BLV infections in draught animals in tropical countries such as Cambodia. This wide distribution of BIV suggests its association with problems in animal health as reported worldwide, and that a primary BIV infection can predispose death of affected animals by other aggressive pathogens or stresses.
Asunto(s)
Anticuerpos Antivirales/sangre , Enfermedades de los Bovinos/epidemiología , Leucosis Bovina Enzoótica/epidemiología , Virus de la Inmunodeficiencia Bovina/aislamiento & purificación , Infecciones por Lentivirus/veterinaria , Virus de la Leucemia Bovina/aislamiento & purificación , Animales , Búfalos/virología , Cambodia , Bovinos/virología , Enfermedades de los Bovinos/inmunología , Industria Lechera , Leucosis Bovina Enzoótica/inmunología , Femenino , Virus de la Inmunodeficiencia Bovina/inmunología , Inmunodifusión , Infecciones por Lentivirus/epidemiología , Infecciones por Lentivirus/inmunología , Virus de la Leucemia Bovina/inmunología , Carne/virología , Especificidad de la EspecieRESUMEN
Experimental infection of cattle with bovine immunodeficiency virus (BIV) is characterized by persistent, low levels of virus replication in the absence of clinical disease. A virus neutralization (VN) assay was developed to examine the role of VN antibodies in controlling virus replication in cattle experimentally infected with the BIV(R29) isolate of BIV. All animals developed VN antibody, but there was no correlation between VN titres and restriction of virus replication in vivo. BIV infection did not induce high-titred, cross-neutralizing antibody and there was no evidence for antigenic variation through more than 4 years in vivo. Genetic comparisons among the BIV(R29) inoculum virus and viruses isolated from infected animals identified only limited genetic variation during 4 years in vivo. Moreover, there was no evidence that the observed variation was due to selection. Analyses of genetic diversity in the virus stock used for inoculation indicated a fairly homogeneous population. In the absence of high levels of virus replication and overt clinical disease, there appeared to be little selection of virus variants, resulting in antigenic and genetic stability of BIV(R29) during long-term, persistent infection.
Asunto(s)
Variación Antigénica/inmunología , Variación Genética , Virus de la Inmunodeficiencia Bovina/genética , Virus de la Inmunodeficiencia Bovina/inmunología , Latencia del Virus , Secuencia de Aminoácidos , Animales , Anticuerpos Antivirales/inmunología , Variación Antigénica/genética , Bovinos , Células Cultivadas , Virus de la Inmunodeficiencia Bovina/aislamiento & purificación , Masculino , Datos de Secuencia Molecular , Pruebas de Neutralización , Factores de TiempoRESUMEN
Recombinant 26 kDa capsid (CA) proteins of bovine lentiviruses, bovine immunodeficiency virus (BIV) and Jembrana disease virus (JDV), were expressed in Escherichia coli and utilised as antigens for an enzyme-linked immunosorbent assay (ELISA) and a western immunoblot (WIB) procedure for the detection of antibody in dairy cattle in Western Australia. A total of 690 serum samples, 30 from each of 23 farms, were tested by ELISA with a JDV CA protein antigen, and antibody was detected in 3.8% (p<0.05) of the sera. Nine sera from each farm were also tested by WIB with JDV CA protein antigens and antibody was detected in 15.9% of these samples. All ELISA-positive results were also WIB-positive, and all sera antibody-positive by WIB with JDV CA protein antigens were also antibody-positive by the WIB using recombinant BIV CA antigens. This study showed that recombinant protein antigens can be used for serological tests to detect bovine lentivirus infection in Australia.
Asunto(s)
Enfermedades de los Bovinos/epidemiología , Virus de la Inmunodeficiencia Bovina/aislamiento & purificación , Infecciones por Lentivirus/veterinaria , Animales , Anticuerpos Antivirales/sangre , Antígenos Virales/biosíntesis , Western Blotting/veterinaria , Cápside/inmunología , Bovinos , Enfermedades de los Bovinos/inmunología , Electroforesis en Gel de Poliacrilamida/veterinaria , Ensayo de Inmunoadsorción Enzimática/veterinaria , Femenino , Virus de la Inmunodeficiencia Bovina/inmunología , Infecciones por Lentivirus/epidemiología , Infecciones por Lentivirus/inmunología , Proteínas Recombinantes , Estudios Seroepidemiológicos , Australia Occidental/epidemiologíaRESUMEN
After describing the results of BIV research during the past years experimental data are presented which indicate that BIV does not cause any clinical symptoms after infection and that no correlation exists with the other widely spread retrovirus in the bovine, the bovine leukosis virus (BLV). Since contact obviously did not lead to a horizontal transmission it is suggested that transmission occurs, as in the cat, vertically from dam to offspring. It was also found that a long period of time after infection can elapse before antibodies against BIV can be detected. It is also quite clear that HIV and BIV do not have much in common except that both are lentiviruses.
Asunto(s)
Enfermedades de los Bovinos/virología , VIH , Virus de la Inmunodeficiencia Bovina/patogenicidad , Infecciones por Lentivirus/veterinaria , Animales , Anticuerpos Antivirales/sangre , Bovinos , Enfermedades de los Bovinos/epidemiología , Enfermedades de los Bovinos/inmunología , Enfermedades de los Bovinos/transmisión , Leucosis Bovina Enzoótica/virología , Femenino , Estudios de Seguimiento , VIH/clasificación , VIH/fisiología , Infecciones por VIH/transmisión , Infecciones por VIH/virología , Humanos , Virus de la Inmunodeficiencia Bovina/clasificación , Virus de la Inmunodeficiencia Bovina/inmunología , Virus de la Inmunodeficiencia Bovina/aislamiento & purificación , Infecciones por Lentivirus/epidemiología , Infecciones por Lentivirus/inmunología , Infecciones por Lentivirus/transmisión , Infecciones por Lentivirus/virología , Virus de la Leucemia Bovina/clasificación , Virus de la Leucemia Bovina/inmunología , Linfoma no Hodgkin/epidemiología , Linfoma no Hodgkin/veterinaria , Linfoma no Hodgkin/virología , Masculino , Especificidad de la EspecieRESUMEN
PIP: The founder of the Indian Health Organisation, Ishwar Gilada, was arrested in April 1999 for administering Manisyl, a bovine immunodeficiency virus vaccine, to AIDS patients in 1994 (3 of these patients have since died). The investigation into Gilada's practices began in September 1995, when a patient took Gilada to court and the Drug Controller of India testified that Gilada had not received the mandatory clearance to conduct patient trials using Manisyl. The developer of the vaccine, US-based veterinarian Bhairab Bhattacharya, also allegedly tested it on some HIV-positive prostitutes in Calcutta. The Florida-based manufacturers of the vaccine have disappeared.^ieng
Asunto(s)
Vacunas contra el SIDA , Crimen , Aprobación de Drogas , Virus de la Inmunodeficiencia Bovina/inmunología , Humanos , IndiaRESUMEN
A 120-amino-acid polypeptide selected from the transmembrane protein region (tTM) and the major capsid protein p26 of bovine immunodeficiency-like virus (BIV) were expressed as fusion proteins from recombinant baculoviruses. The antigenic reactivity of both recombinant fusion proteins was confirmed by Western blot with bovine and rabbit antisera to BIV. BIV-negative bovine sera and animal sera positive for bovine syncytial virus and bovine leukemia virus failed to recognize the recombinant fusion proteins, thereby showing the specificity of the BIV Western blot. One hundred and five bovine serum samples were tested for the presence of anti-BIV antibodies by the recombinant protein-based Western blot and a reference Western blot assay using cell culture-derived virions as test antigens. There was a 100% concordance when the p26 fusion protein was used in the Western blot. However, the Western blot using the tTM fusion protein as its test antigen identified four BIV-positive bovine sera which had tested negative in both the p26 recombinant-protein-based and the reference Western blot assays. This resulted in the lower concordance of 96.2% between the tTM-protein-based and reference Western blot assays. The results of this study showed that the recombinant p26 and tTM proteins can be used as test antigens for the serodetection of BIV-infection in animals.
Asunto(s)
Western Blotting/métodos , Cápside/inmunología , Virus de la Inmunodeficiencia Bovina/inmunología , Virus de la Inmunodeficiencia Bovina/aislamiento & purificación , Proteínas del Envoltorio Viral/inmunología , Animales , Anticuerpos Antivirales , Especificidad de Anticuerpos , Antígenos Virales/análisis , Antígenos Virales/genética , Antígenos Virales/inmunología , Baculoviridae/genética , Western Blotting/normas , Cápside/análisis , Cápside/genética , Bovinos , Regulación Viral de la Expresión Génica , Virus de la Inmunodeficiencia Bovina/genética , Plásmidos , Conejos , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Análisis de Secuencia de ADN , Proteínas del Envoltorio Viral/análisis , Proteínas del Envoltorio Viral/genéticaRESUMEN
The development of the antibody response to peptides of the transmembrane glycoprotein of bovine immunodeficiency virus (BIV) was followed over a period of 50 weeks in six cattle experimentally infected with the BIV(FL112) isolate. Antibody was detected by an enzyme immunoassay using either a linear or a cyclized peptide with structural features common to an immunodominant region of other lentiviruses. The assay was specific for BIV, detecting antibody in bovine sera to BIV(FL112) or BIV(R29) but not to six other common viruses of cattle. Antibody was present in the sera of all cattle inoculated with BIV(FL112) within 4 weeks of infection, peaked between 10 and 30 weeks and persisted in most cattle during the 50 weeks of observation. These features indicate that this assay may be useful in identifying cattle infected with other strains of BIV in the field.
Asunto(s)
Anticuerpos Antivirales/inmunología , Virus de la Inmunodeficiencia Bovina/inmunología , Infecciones por Lentivirus/inmunología , Péptidos/inmunología , Proteínas del Envoltorio Viral/inmunología , Secuencia de Aminoácidos , Animales , Especificidad de Anticuerpos , Bovinos , Secuencia Conservada , Glicoproteínas/inmunología , Virus de la Inmunodeficiencia Bovina/fisiología , Epítopos Inmunodominantes , Datos de Secuencia Molecular , Factores de Tiempo , Latencia del VirusRESUMEN
A seroprevalence study of bovine lentivirus, known as bovine immunodeficiency virus (BIV), was conducted in 12 different dairy herds in Hokkaido, where some herds were a high prevalence of bovine leukemia virus (BLV) infection. Amongst 611 cattle, 28.6% of cattle were BLV-seropositive, and 11.7% of cattle were seropositive for BIV, while 4.2% of cattle were seropositive for both BIV and BLV. For the isolation of BIV, 19 samples of peripheral blood mononuclear cells (PBMC) and one sample of milk-derived leukocytes were prepared from BIV-seropositive cows. These PBMC and leukocyte preparations were then co-cultivated with cc81 cells, a cat cell line transformed by mouse sarcoma virus. BIV was isolated from 17 PBMC and one milk-derived leukocyte samples. The isolated viruses showed slow replication and syncytia formation. Major core antigen, p26 from these isolates were reacted with anti-BIV (American isolate R-29) serum. In addition, proviral DNA was detected in blood and milk samples by nested polymerase chain reaction and subsequent Southern blot hybridization. Nucleotide sequence analysis of the amplified pol gene products showed its 99.0 to 99.7% homology to that of BIV R-29. These results indicate that the Japanese BIV isolates appear to be antigenically and genetically similar to the American R-29. Since BIV was isolated from milk samples, BIV could possibly be transmitted through milk. This is the first report of BIV isolation in Japan.